Evaluation of the TriActiv ProGuard System During Carotid Artery Stenting

PHASE2/PHASE3TerminatedINTERVENTIONAL
Enrollment

400

Participants

Timeline

Start Date

November 30, 2006

Study Completion Date

June 30, 2007

Conditions
Carotid Stenosis
Interventions
DEVICE

Carotid Stent Implantation

DEVICE

Embolic Protection

Trial Locations (34)

10021

Lenox Hill Hospital, New York

11030

North Shore University Hospital, Manhasset

14209

Millard Fillmore Hospital, Buffalo

Millard Fillmore, Buffalo

17110

Pinnacle Health Hospital, Harrisburg

19610

St. Joseph Medical Center, Wyomissing

22527

Herzzentrum Hamburg, Hamburg

23226

Virginia Cardiovascular Specialists/St. Mary's Hospital, Richmond

27103

Forsyth Medical Center, Winston-Salem

29204

Sisters of Charity Providence Hospital, Columbia

30309

Piedmont Hospital, Atlanta

30322

Crawford Long Hospital, Atlanta

Emory University Hospital, Atlanta

32209

University of Florida, Jacksonville

33140

Mt. Sinai Medical Center, Miami Beach

33176

Baptist Hospital of Miami, Miami

33462

Florida Crdiovascular Research at JFK Medical Center, Atlantis

36532

Thomas Hospital, Fairhope

37660

Wellmont Holston Valley Medical Center, Kingsport

37920

Baptist Hospital of East Tennessee, Knoxville

38138

Methodist Germantown, Germantown

40202

Jewish Hospital, Louisville

44035

Lorain Community Hospital, Elyria

44145

St. John West Shore Hospital, Westlake

44195

Cleveland Clinic, Cleveland

60389

CardioVasculares Centrum Frankfurt Sankt Katharinen, Frankfurt

81737

Stadtisches Krankenhaus Neuperlach, Bayern

84143

LDS Hospital, Salt Lake City

90017

Good Samaritan Hospital, Los Angeles

90210

Brotman Medical Center, Beverly Hills

94040

El Camino Hospital, Mountain View

94305

Stanford University Medical Center, Stanford

35294-0012

University of Alabama Birmingham, Birmingham

02215

Beth Israel Deaconess Medical Center, Boston

Sponsors
All Listed Sponsors
lead

Kensey Nash Corporation

INDUSTRY

NCT00395785 - Evaluation of the TriActiv ProGuard System During Carotid Artery Stenting | Biotech Hunter | Biotech Hunter